Literature DB >> 15727724

The lectin-like oxidized low-density lipoprotein receptor and its role in atherosclerosis.

Mehmet Cilingiroglu1, Kerem Ozer.   

Abstract

The lectin-like oxidized low-density lipoprotein receptor (LOX-1), a recently identified receptor that plays a role in the uptake of oxidized low-density lipoproteins into endothelial cells, has a pivotal role in the pathogenesis of atherosclerosis. The ways this receptor takes part in atherosclerosis is through uptake of oxidized low-density lipoproteins into endothelial cells, smooth muscle cells, and macrophages; decreasing nitric oxide production; increasing inflammatory cell recruitment; and increasing smooth muscle cell proliferation. LOX-1 is inducible and regulated by multiple factors known to underlie atherogenesis. Further understanding of this receptor may lead to potential molecular targets for prevention and treatment of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15727724     DOI: 10.1007/s11883-005-0031-3

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  43 in total

1.  Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages.

Authors:  Y Iwashima; M Eto; A Hata; K Kaku; S Horiuchi; F Ushikubi; H Sano
Journal:  Biochem Biophys Res Commun       Date:  2000-10-22       Impact factor: 3.575

Review 2.  Hepatic and extrahepatic scavenger receptors: function in relation to disease.

Authors:  V Terpstra; E S van Amersfoort; A G van Velzen; J Kuiper; T J van Berkel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

Review 3.  Receptors for oxidized low density lipoprotein.

Authors:  U P Steinbrecher
Journal:  Biochim Biophys Acta       Date:  1999-01-04

4.  Redox-sensitive regulation of lox-1 gene expression in vascular endothelium.

Authors:  M Nagase; K Ando; T Nagase; S Kaname; T Sawamura; T Fujita
Journal:  Biochem Biophys Res Commun       Date:  2001-03-02       Impact factor: 3.575

5.  Induction of the oxLDL receptor LOX-1 by endothelin-1 in human endothelial cells.

Authors:  H Morawietz; N Duerrschmidt; B Niemann; J Galle; T Sawamura; J Holtz
Journal:  Biochem Biophys Res Commun       Date:  2001-06-22       Impact factor: 3.575

6.  LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria.

Authors:  T Shimaoka; N Kume; M Minami; K Hayashida; T Sawamura; T Kita; S Yonehara
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

7.  Accumulation of LOX-1 ligand in plasma and atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits: identification by a novel enzyme immunoassay.

Authors:  M Kakutani; M Ueda; T Naruko; T Masaki; T Sawamura
Journal:  Biochem Biophys Res Commun       Date:  2001-03-23       Impact factor: 3.575

8.  Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells.

Authors:  T Murase; N Kume; R Korenaga; J Ando; T Sawamura; T Masaki; T Kita
Journal:  Circ Res       Date:  1998-08-10       Impact factor: 17.367

9.  Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein.

Authors:  H Moriwaki; N Kume; T Sawamura; T Aoyama; H Hoshikawa; H Ochi; E Nishi; T Masaki; T Kita
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-10       Impact factor: 8.311

10.  Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts.

Authors:  B Björkerud; S Björkerud
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-03       Impact factor: 8.311

View more
  1 in total

1.  Rapamycin Inhibits Oxidized Low Density Lipoprotein Uptake in Human Umbilical Vein Endothelial Cells via mTOR/NF-κB/LOX-1 Pathway.

Authors:  Yan-De Zhou; Xue-Qin Cao; Zhi-Hua Liu; Yong-Jun Cao; Chun-Feng Liu; Yan-Lin Zhang; Ying Xie
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.